NEWS

FDA grants binx health CLIA-Waiver for its first-of-kind binx io platform for chlamydia and gonorrhea testing

Learn More

News

News

FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings

FDA NEWS RELEASE

News

BINX HEALTH RECEIVES FDA CLIA WAIVER FOR CHLAMYDIA AND GONORRHEA TEST, EXPANDING CRITICAL ACCESS TO SINGLE-VISIT DIAGNOSES

First ever 30-minute, CLIA-waived, molecular PCR Test for CT/NG now available for OBGYN, physician offices and retail settings holding certificates of waiver

News

binx health™ Collaborates with Amazon Business for Delivery of COVID-19 Sample Collection Kits to U.S. Businesses, Schools and Governments

binx health, a population health technology company that provides convenient healthcare solutions, announced today that its FDA emergency-use authorized at-home nasal swab COVID-19 Sample Collection Kit is now available for…

News

Veteran Healthcare Leader David P. King Joins binx health Board of Directors

Former LabCorp Chairman and CEO joins binx board during period of rapid growth

News

binx health Enters into Distribution Agreement for National Launch of the FDA-cleared binx io

binx molecular point-of-care platform poised to transform care for chlamydia and gonorrhea, the two most tested for sexually-transmitted infections

News

New York Film Academy Selects binx health for COVID-19 Testing, Creating Instant Platform for Broad Health Offerings Across Multiple Campuses

binx positioned to “switch on care at scale” in New York, Los Angeles and Miami

News

binx health receives EUA authorizing At-Home COVID-19 sample collection by universities and employers

Latest amendment adds important tool for student health and employers in the fight against COVID-19

News

College health insurer Wellfleet teams up with binx health to keep students safe and campuses open in the fight against COVID-19

Wellfleet taps binx for convenient, in-dorm sample collection and bespoke technology solutions to help arrest virus spread

binx io with COVID-19 cartridge
News

Sherlock Biosciences and binx health Announce Global Partnership to Develop First CRISPR-based Point-of-care Test for COVID-19

binx health’s Proven Molecular io Platform Combined with SHERLOCK™ CRISPR Technology Will Enable Rapid, Accurate Testing for SARS-CoV-2 in Retail and Near-patient Settings